IDEAYA Biosciences (IDYA) Competitors $19.13 -1.44 (-7.00%) Closing price 04:00 PM EasternExtended Trading$19.12 0.00 (-0.03%) As of 05:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends IDYA vs. RVMD, TLX, BBIO, LEGN, AXSM, BPMC, CYTK, LNTH, NUVL, and ELANShould you be buying IDEAYA Biosciences stock or one of its competitors? The main competitors of IDEAYA Biosciences include Revolution Medicines (RVMD), Telix Pharmaceuticals Limited American Depositary Shares (TLX), BridgeBio Pharma (BBIO), Legend Biotech (LEGN), Axsome Therapeutics (AXSM), Blueprint Medicines (BPMC), Cytokinetics (CYTK), Lantheus (LNTH), Nuvalent (NUVL), and Elanco Animal Health (ELAN). These companies are all part of the "pharmaceutical products" industry. IDEAYA Biosciences vs. Revolution Medicines Telix Pharmaceuticals Limited American Depositary Shares BridgeBio Pharma Legend Biotech Axsome Therapeutics Blueprint Medicines Cytokinetics Lantheus Nuvalent Elanco Animal Health Revolution Medicines (NASDAQ:RVMD) and IDEAYA Biosciences (NASDAQ:IDYA) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, earnings, dividends, community ranking, media sentiment, risk, analyst recommendations, valuation and institutional ownership. Does the media prefer RVMD or IDYA? In the previous week, Revolution Medicines had 17 more articles in the media than IDEAYA Biosciences. MarketBeat recorded 24 mentions for Revolution Medicines and 7 mentions for IDEAYA Biosciences. Revolution Medicines' average media sentiment score of 0.28 beat IDEAYA Biosciences' score of 0.27 indicating that Revolution Medicines is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Revolution Medicines 3 Very Positive mention(s) 4 Positive mention(s) 6 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Neutral IDEAYA Biosciences 0 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral Do insiders and institutionals hold more shares of RVMD or IDYA? 94.3% of Revolution Medicines shares are owned by institutional investors. Comparatively, 98.3% of IDEAYA Biosciences shares are owned by institutional investors. 8.0% of Revolution Medicines shares are owned by insiders. Comparatively, 3.5% of IDEAYA Biosciences shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Is RVMD or IDYA more profitable? IDEAYA Biosciences' return on equity of -26.74% beat Revolution Medicines' return on equity.Company Net Margins Return on Equity Return on Assets Revolution MedicinesN/A -33.67% -30.08% IDEAYA Biosciences N/A -26.74%-25.54% Do analysts prefer RVMD or IDYA? Revolution Medicines presently has a consensus target price of $66.31, suggesting a potential upside of 72.95%. IDEAYA Biosciences has a consensus target price of $53.58, suggesting a potential upside of 180.10%. Given IDEAYA Biosciences' higher possible upside, analysts plainly believe IDEAYA Biosciences is more favorable than Revolution Medicines.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Revolution Medicines 0 Sell rating(s) 0 Hold rating(s) 12 Buy rating(s) 1 Strong Buy rating(s) 3.08IDEAYA Biosciences 0 Sell rating(s) 2 Hold rating(s) 12 Buy rating(s) 1 Strong Buy rating(s) 2.93 Which has more volatility & risk, RVMD or IDYA? Revolution Medicines has a beta of 1.45, meaning that its share price is 45% more volatile than the S&P 500. Comparatively, IDEAYA Biosciences has a beta of 0.82, meaning that its share price is 18% less volatile than the S&P 500. Does the MarketBeat Community believe in RVMD or IDYA? IDEAYA Biosciences received 47 more outperform votes than Revolution Medicines when rated by MarketBeat users. However, 76.61% of users gave Revolution Medicines an outperform vote while only 71.72% of users gave IDEAYA Biosciences an outperform vote. CompanyUnderperformOutperformRevolution MedicinesOutperform Votes9576.61% Underperform Votes2923.39% IDEAYA BiosciencesOutperform Votes14271.72% Underperform Votes5628.28% Which has stronger valuation & earnings, RVMD or IDYA? IDEAYA Biosciences has higher revenue and earnings than Revolution Medicines. Revolution Medicines is trading at a lower price-to-earnings ratio than IDEAYA Biosciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioRevolution Medicines$742K8,692.07-$436.37M-$3.57-10.74IDEAYA Biosciences$7M239.23-$274.48M-$3.30-5.80 SummaryIDEAYA Biosciences beats Revolution Medicines on 9 of the 16 factors compared between the two stocks. Get IDEAYA Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for IDYA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IDYA vs. The Competition Export to ExcelMetricIDEAYA BiosciencesPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.67B$7.20B$5.81B$8.39BDividend YieldN/A2.79%4.75%3.98%P/E Ratio-5.806.1524.9519.21Price / Sales239.23187.68375.54110.22Price / CashN/A65.6738.0534.58Price / Book1.586.447.334.28Net Income-$274.48M$139.03M$3.18B$247.04M7 Day Performance-10.23%-5.52%-4.42%-4.36%1 Month Performance-19.08%-8.56%-6.07%-5.60%1 Year Performance-58.61%-14.59%11.42%3.38% IDEAYA Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IDYAIDEAYA Biosciences4.1007 of 5 stars$19.13-7.0%$53.58+180.1%-55.5%$1.67B$7M-5.8080Gap UpRVMDRevolution Medicines4.6581 of 5 stars$41.45+0.3%$66.25+59.8%+36.7%$7.01B$11.58M-11.61250Earnings ReportAnalyst ForecastAnalyst RevisionNews CoverageTLXTelix Pharmaceuticals Limited American Depositary SharesN/A$20.76+6.4%$22.00+6.0%N/A$6.99B$516.72M0.00N/AHigh Trading VolumeBBIOBridgeBio Pharma4.7065 of 5 stars$36.25-1.6%$51.67+42.5%-2.0%$6.84B$221.90M-12.70400Analyst RevisionLEGNLegend Biotech1.9622 of 5 stars$36.82-7.3%$79.50+115.9%-46.6%$6.73B$285.14M-38.791,800Positive NewsAXSMAxsome Therapeutics4.7466 of 5 stars$131.10-4.8%$158.79+21.1%+54.7%$6.39B$385.69M-21.88380Analyst ForecastBPMCBlueprint Medicines2.8663 of 5 stars$92.49+0.3%$123.83+33.9%+1.5%$5.91B$508.82M-85.69640Analyst ForecastCYTKCytokinetics3.9743 of 5 stars$48.38-3.7%$82.00+69.5%-37.8%$5.71B$7.53M-9.00250Earnings ReportAnalyst ForecastAnalyst RevisionLNTHLantheus4.51 of 5 stars$79.12+1.1%$131.86+66.6%+45.1%$5.55B$1.50B13.29700Earnings ReportNUVLNuvalent2.1402 of 5 stars$78.08-1.8%$113.10+44.9%-14.0%$5.54BN/A-22.4540Earnings ReportAnalyst ForecastELANElanco Animal Health3.6566 of 5 stars$11.14+1.0%$16.00+43.7%-30.2%$5.50B$4.42B27.849,300Earnings ReportAnalyst Revision Related Companies and Tools Related Companies Revolution Medicines Alternatives Telix Pharmaceuticals Limited American Depositary Shares Alternatives BridgeBio Pharma Alternatives Legend Biotech Alternatives Axsome Therapeutics Alternatives Blueprint Medicines Alternatives Cytokinetics Alternatives Lantheus Alternatives Nuvalent Alternatives Elanco Animal Health Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:IDYA) was last updated on 3/3/2025 by MarketBeat.com Staff From Our PartnersDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredElon Musk Wants to Audit Fort Knox—What It Means for Your RetirementYou can take advantage of the coming tariff-fueled gold melt-up right inside your IRA or 401(k) – 100% TAX-FRE...Colonial Metals | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredTrump’s Victory Could Spark Major Gains for Gold – Don’t Miss Out This "Patriot's Tax Shield" lets you defend your wealth with real, solid gold. Our exclusive, free wealth pr...American Alternative | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredThe Deep State Surveillance Plot To Sabotage President TrumpThere's a Trump approved IRS-loophole which allows you to steer clear of government overreach and move your re...American Hartford Gold | SponsoredUrgent update to my gold outlookTrump’s Policies Are Fueling a Gold Boom—Here’s Your Chance to Profit Donald Trump’s bold policies are driv...Golden Portfolio | SponsoredCollect $7k per month from Tesla’s SECRET dividendThere's a little-known secret about Tesla that even seasoned investors don't know. Despite not paying a tra...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IDEAYA Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share IDEAYA Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IDYA Stock Alerts